Robert Liddiard, DPM
Foot & Ankle Surgery · Riverton, UTNPI 1588004865
Payments from drug & device makers
Across 75 payments — averaging $20.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$329
- Smith+Nephew$187
- Orthofix Medical, Inc.$117
- Nevro Corp.$99
- Bioventus LLC$87
- Paratek Pharmaceuticals, Inc.$78
- plus $665 from 22 others
What the payments were for
- Food & beverage$1,563100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 12 | $329 |
| Smith+Nephew | 10 | $187 |
| Orthofix Medical, Inc. | 6 | $117 |
| Nevro Corp. | 5 | $99 |
| Bioventus LLC | 4 | $87 |
| Paratek Pharmaceuticals, Inc. | 5 | $78 |
| Bard Peripheral Vascular, Inc. | 1 | $73 |
| Paragon 28, Inc. | 4 | $64 |
| Kowa Pharmaceuticals America, Inc. | 3 | $52 |
| Globus Medical | 2 | $47 |
| AbbVie | 3 | $44 |
| Treace Medical Concepts, Inc. | 2 | $39 |
| Acell, Inc. | 2 | $38 |
| Osiris Therapeutics Inc. | 2 | $36 |
| Resmed Corp | 1 | $31 |
| Evolution Surgical, Inc | 1 | $25 |
| Medtronic | 1 | $25 |
| Medela LLC | 1 | $24 |
| Boston Scientific | 1 | $22 |
| Next Science LLC | 1 | $21 |
| Averitas Pharma Inc. | 1 | $21 |
| Organogenesis Inc. | 1 | $19 |
| Biocomposites Inc | 1 | $18 |
| Zimmer Biomet | 1 | $14 |
| Stimwave Technologies Incorporated | 1 | $14 |
| Integra Lifesciences Corporation | 1 | $13 |
| Merck | 1 | $13 |
| KCI USA, Inc. | 1 | $12 |
How this compares
$1,563 in reported general payments places this provider in the 30th percentile of 104 foot & ankle surgery providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clindamycin Hcl | 25 | $281 |
| Gabapentin | 21 | $222 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $146 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Riverton
- Braden BrklacichRiverton$7K
- Gregory AndersonSalt Lake City$1.6M
- Ryan RigbyLogan$1M
- Florian NickischSalt Lake City$474K
- Carl van GilsSt George$361K
- Brian LiljenquistSalt Lake City$263K
- Douglas TooleSalt Lake City$258K
- Francis ClarkWest Jordan$125K
- David SeegmillerSalt Lake City$120K
- Scott ClarkWest Jordan$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.